BR112014000889A2 - tratamento para hipoxia - Google Patents

tratamento para hipoxia

Info

Publication number
BR112014000889A2
BR112014000889A2 BR112014000889A BR112014000889A BR112014000889A2 BR 112014000889 A2 BR112014000889 A2 BR 112014000889A2 BR 112014000889 A BR112014000889 A BR 112014000889A BR 112014000889 A BR112014000889 A BR 112014000889A BR 112014000889 A2 BR112014000889 A2 BR 112014000889A2
Authority
BR
Brazil
Prior art keywords
hypoxia
treatment
hypoxia treatment
individual
hmf
Prior art date
Application number
BR112014000889A
Other languages
English (en)
Portuguese (pt)
Inventor
Stern Warren
Original Assignee
Aesrx Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aesrx Llc filed Critical Aesrx Llc
Publication of BR112014000889A2 publication Critical patent/BR112014000889A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112014000889A 2011-07-15 2012-07-12 tratamento para hipoxia BR112014000889A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161508260P 2011-07-15 2011-07-15
PCT/US2012/046427 WO2013012670A1 (en) 2011-07-15 2012-07-12 Treatment for hypoxia

Publications (1)

Publication Number Publication Date
BR112014000889A2 true BR112014000889A2 (pt) 2017-10-31

Family

ID=46551919

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014000889A BR112014000889A2 (pt) 2011-07-15 2012-07-12 tratamento para hipoxia

Country Status (7)

Country Link
US (1) US9918958B2 (enExample)
EP (1) EP2731602A1 (enExample)
JP (1) JP2014520854A (enExample)
AU (1) AU2012284361B2 (enExample)
BR (1) BR112014000889A2 (enExample)
CA (1) CA2841954C (enExample)
WO (1) WO2013012670A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016043849A2 (en) 2014-07-24 2016-03-24 Global Blood Therapeutics, Inc. Compounds for treating acute respiratory distress syndrome or a negative effect thereof
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
JP7265237B2 (ja) * 2017-07-27 2023-04-26 共栄化学工業株式会社 毛髪用組成物及び皮膚外用組成物
EP4415698A1 (en) * 2021-10-11 2024-08-21 D-Cap Llc 5-hydroxymethylfurfural for the treatment of mitochondrial dysfunction
US11458144B1 (en) 2021-12-23 2022-10-04 King Abdulaziz University Methods for using 5-HMF analogs with increased solubility to inhibit or reverse RBC sickling
CN117085005A (zh) * 2023-10-08 2023-11-21 山东省科学院生物研究所 5-羟甲基-2-呋喃甲酸在制备促血管生成相关产品中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7160910B2 (en) 2002-12-04 2007-01-09 Xechem International, Inc. Anti-sickling agents
EP2255623A1 (en) * 2009-05-26 2010-12-01 Volker Wagner-Solbach Plant nutriments
CA2790170A1 (en) * 2010-05-18 2011-11-24 Aesrx Llc Treatment for altitudinal hypoxia

Also Published As

Publication number Publication date
AU2012284361B2 (en) 2016-11-17
JP2014520854A (ja) 2014-08-25
AU2012284361A2 (en) 2014-02-13
WO2013012670A1 (en) 2013-01-24
EP2731602A1 (en) 2014-05-21
US20130018092A1 (en) 2013-01-17
AU2012284361A1 (en) 2014-01-30
CA2841954A1 (en) 2013-01-24
CA2841954C (en) 2020-05-05
US9918958B2 (en) 2018-03-20

Similar Documents

Publication Publication Date Title
JO3091B1 (ar) مشتقات حمض 3- فنيل بروبيونيك متفرعة واستخداماتها
BR112015022197A2 (pt) tratamento de cataplexia
BR112015001101A2 (pt) formas cristalinas de um inibidor de prolil hidroxilase
BR112016009889A2 (pt) ?compostos agonistas duplos gip-glp-1 e métodos?
BR112014007193A2 (pt) derivados de pirazoloquinolinona, preparação dos mesmos e uso terapêutico dos mesmos
BR112016010454A2 (pt) métodos para tratar uma taupatia
BR112015012987A2 (pt) composições compreendendo anticorpos anti-cd38 e lenalidomida
BR112015005369A2 (pt) inibidores de usp30 e métodos para sua utilização
BR112013020517A2 (pt) dispositivo de segurança
BR112013025732A2 (pt) composto de imidazo-oxazina ou sal do mesmo
MX2020001258A (es) Moduladores del factor del complemento b.
BR112014003079A2 (pt) derivado de 1,2,3,4-tetra-hidroquinolina útil para o tratamento de diabetes
BR112014004219A2 (pt) pirano[3,2-d][1,3]tiazol como inibidores de glicosidase
BR112014009866A2 (pt) formulações de anticorpos e métodos
BR112014002141A2 (pt) crizotinib para uso no tratamento de câncer
BR112013029256A8 (pt) combinação farmacêutica para uso no tratamento de pacientes com diabetes tipo 2
BR112013022052A2 (pt) ligantes antagonísticos de dr3
BR112014000123A2 (pt) sistema e processo para conversão de matéria orgânica em produto torrado
BR112015021332A2 (pt) sal de sódio de ácido (2s, 5r)-6-benzilóxi-7-oxo-1,6-diaza-biciclo [3.2.1] octano-2-carboxílico e sua preparação
MX356025B (es) Uso de glicopirrolato para tratar taquicardia.
MX2013011124A (es) Compuestos para el tratamiento del sindrome metabolico.
BR112014000889A2 (pt) tratamento para hipoxia
BR112014005935A2 (pt) derivados de anilina, sua preparação e sua aplicação terapêutica
CO6920289A2 (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib.
BR112014008783A2 (pt) compostos para o tratamento e profilaxia da doença causada por vírus sincicial respiratório

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11N Dismissal: publication cancelled

Free format text: REFERENTE A RPI NO 2424 DE 20/06/2017, POR TER SIDO INDEVIDO.

B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired